This compound is primarily utilized in the field of medicinal chemistry and drug development, particularly in the design of bioactive molecules targeting neurological and psychiatric disorders. Its structure, featuring a piperidine ring with an amino-pyridine moiety and a fluoroethyl group, makes it a valuable scaffold for synthesizing compounds that interact with central nervous system receptors. It has been explored for its potential as a precursor in the synthesis of ligands for serotonin or dopamine receptors, which are critical in treating conditions like depression, anxiety, and schizophrenia. Additionally, the fluorine atom in the fluoroethyl group enhances the compound’s metabolic stability and bioavailability, making it a promising candidate for further pharmacological optimization. Researchers also investigate its role in developing radiolabeled probes for imaging studies, aiding in the understanding of receptor distribution and function in the brain.